المؤلفون: Venkatakrishnan, K, Ecsedy, JA

المصدر: Clinical Pharmacology & Therapeutics; Jan2017, Vol. 101 Issue 1, p99-113, 15p

مصطلحات موضوعية: ANTINEOPLASTIC agents, DRUG development, ONCOLOGY, PHARMACODYNAMICS, PHARMACOLOGY

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Owonikoko TK; Winship Cancer Institute of Emory University, Atlanta, Georgia. Electronic address: towonik@emory.edu., Niu H; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Nackaerts K; KU Leuven, Universitaire Ziekenhuizen, Leuven, Belgium., Csoszi T; Hetenyi G Korhaz, Szolnok, Hungary., Ostoros G; Orszagos Koranyi TBC es Pulmonologiai Intezet, Budapest, Hungary., Mark Z; Tudogyogyintezet Torokbalint, Torokbalint, Hungary., Baik C; University of Washington Seattle Cancer Care Alliance, Seattle, Washington., Joy AA; University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada., Chouaid C; CHI de Créteil, Créteil, France., Jaime JC; Hospital Universitario Virgen del Rocio, Seville, Spain., Kolek V; Fakultni Nemocnice Olomouc, Olomouc, Czech Republic., Majem M; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Roubec J; Fakultni Nemocnice Ostrava, Ostrava Poruba, Czech Republic., Santos ES; Lynn Cancer Institute/Boca Raton Regional Hospital, Boca Raton, Florida., Chiang AC; Yale University School of Medicine, New Haven, Connecticut., Speranza G; Université de Sherbrooke, Centre intégré de cancérologie de la Montéregie, Hôpital Charles Le Moyne, Greenfield Park, Quebec City, Canada., Belani CP; Penn State Cancer Institute, Hershey, Pennsylvania., Chiappori A; H. Lee Moffitt Cancer Center, Tampa, Florida., Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida., Czebe K; Tudogyogyintezet Torokbalint, Törökbálint, Hungary., Byers L; Tudogyogyintezet Torokbalint, Törökbálint, Hungary., Bahamon B; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Li C; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Sheldon-Waniga E; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Kong EF; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Williams M; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Badola S; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Shin H; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Bedford L; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Ecsedy JA; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Bryant M; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Jones S; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Simmons J; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Leonard EJ; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Ullmann CD; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Spigel DR; Personal Genome Diagnostics, Baltimore, Maryland.

مؤلفون مشاركون: C14018 study investigators

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2020 Feb; Vol. 15 (2), pp. 274-287. Date of Electronic Publication: 2019 Oct 23.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Paclitaxel*, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Azepines ; Biomarkers ; Disease-Free Survival ; Double-Blind Method ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Pyrimidines ; Retrospective Studies ; Treatment Outcome

المؤلفون: Currier MA; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Sprague L; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Rizvi TA; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center; Cincinnati, Ohio, USA., Nartker B; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Chen CY; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Wang PY; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Hutzen BJ; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Franczek MR; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Patel AV; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center; Cincinnati, Ohio, USA., Chaney KE; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center; Cincinnati, Ohio, USA., Streby KA; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA.; Division of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Ecsedy JA; Takeda Pharmaceuticals International Co, Cambridge, MA, USA., Conner J; Virttu Biologics, Ltd, Biocity, Scotland, Newhouse, United Kingdom., Ratner N; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center; Cincinnati, Ohio, USA., Cripe TP; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA.; Division of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA.

المصدر: Oncotarget [Oncotarget] 2017 Mar 14; Vol. 8 (11), pp. 17412-17427.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Azepines/*administration & dosage , Neurilemmoma/*pathology , Neuroblastoma/*pathology , Oncolytic Virotherapy/*methods , Pyrimidines/*administration & dosage, Animals ; Aurora Kinase A/antagonists & inhibitors ; Blotting, Western ; Cell Line, Tumor ; Combined Modality Therapy ; Cytotoxicity, Immunologic/immunology ; Female ; Flow Cytometry ; Herpesvirus 1, Human ; Humans ; Immunity, Innate/immunology ; Immunohistochemistry ; Mice ; Mice, Nude ; Xenograft Model Antitumor Assays